Ассоциация полиморфного варианта (CA)nгена кальцитонина (CALCA) с риском развитияпостменопаузального остеопороза и уровнемкальцитонина в сыворотке крови у русских женщинВолго-Уральского региона России
https://doi.org/10.14341/osteo200912-6
Аннотация
Об авторах
L. SeleznevaR. Khusainova
R. Nurlygayanov
E. Fazlyeva
T. Ziganshin
E. Kozhemyakina
O. Lesnyak
E. Khusnutdinova
Список литературы
1. Alevizaki M., Stevenson J.C., Girgis S.I. et al. Altered calcitonin gene in a young patient with osteoporosis // BMJ. 1989. Vol. 6, № 298 (6682). P. 1215-1216.
2. Andrew T., Antioniades L., Scurrah K.J. et al. Risk of wrist fracture in women is heritable and is infuenced by genes that are largely independent of those infuencing BMD // J Bone Miner Res. 2005. Vol. 20, № 1. P. 67-74.
3. Beringer T.R., Ardill J., H. M. Taggart. Absence of evidence for a role of calcitonin in the etiology of femoral neck fracture // Calcif Tissue Int. 1986. Vol. 39, № 5. P. 300-303.
4. Braga V., Mottes M., Mirandola S. et al. Association of CTR and COLIA1 alleles with BMD values in peri- and postmenopausal women // Calcif Tissue Int. 2000. Vol. 67, № 5. P. 361-366.
5. Chesnut 3rd C.H., Baylink D.J, Sisom K. et al. Basal plasma immunoreactive calcitonin in postmenopausal osteoporosis // Metabolism . 1980. Vol. 29, № 6. P. 559-562.
6. Drews K., Seremak-Mrozikiewicz A., Bartkowiak-Wieczorek J. et al. Genetic polymorphism of the calcitonin receptor gene and bone mineral density in Polish population of postmenopausal women // Ginekol Pol. 2005. Vol. 76, № 8. P. 612-618.
7. Evans R., Marel G., Lancaster E. et al. Bone mass is low in relatives of osteoporosis patients // Ann Intern Med. 1988. Vol. 109. P 870-873.
8. Kim J.G., Choi Y.M., Moon S.Y., Lee J.Y. Association of the calcitonin gene (CA) polymorphism with bone mass and bone responsiveness to hormone therapy in postmenopausal Korean women // Menopause. 2003. Vol. 10, № 6. P. 544-549.
9. Magana J.J., Gomez R., Cisneros B. et al. Association of the CT gene (CA) polymorphism with BMD in osteoporotic Mexican women // Clin Genet. 2006. Vol. 70, № 5. P. 402-408.
10. Mathew C.C. The isolation of high molecular weight eucariotic DNA // Methods in molecular biology. Ed Walker J.M. N.Y.; Haman press, 1984. P. 31-34.
11. Miyao M., Hosoi T., Emi M. et al. Association of bone mineral density with a dinucleotide repeat polymorphism at the calcitonin (CT) locus // J Hum Genet. 2000. Vol. 45, № 6. P. 346-350.
12. Pondel M. Calcitonin and calcitonin receptors: bone and beyond // Int J Exp Pathol. 2000. Vol. 81, № 6. P. 405-422.
13. Ralston S. The genetics of osteoporosis // Bone. 1999. Vol. 25, № 1. P. 85-86.
14. Reginster J.Y. Calcitonin // Rev. Med. Liege. 1996. Vol. 51, № 1. P. 116-119.
15. Seeman E., Hopper J., Bach L. et al. Reduced bone mass in daughters of women with osteoporosis // N. Engl. J. Med. 1989. Vol. 320. P. 554-558.
16. Sugino K., Kure Y., Iwasaki H., Matsumoto A. Does total thyroidectomy induce metabolic bone disturbance? // Int. Surg. 1992. Vol. 77, № 3. P. 178-180.
17. Tiegs R.D., Body J.J., Wahner H.W. et al. Calcitonin secretion in postmenopausal osteoporosis // N. Engl. J. Med. 1985. Vol. 25, № 312(17). P. 1097-1100.
18. Tsukamoto K. A polymorphic CA repeat sequence at the human calcitonin locus // J. Hum. Genet. 1998. Vol. 43, № 2. P. 146-147.
19. Uitterlinden A.G., van Meurs J.B., Rivadeneira F., Pols H.A. Identifying genetic risk factors for osteoporosis // J Musculoskelet Neuronal Interact. 2006. Vol. 6, № 1. P. 16-26.
20. WHO technical report Assessment of fracture risk and its application to screening for postmenopausal osteoporosis // Geneva, 1994. ser. 843. p. 129.
21. Wuster C., Raue F., Meyer C. et al. Long-term excess of endogenous calcitonin in patients with medullary thyroid carcinoma does not affect bone mineral density // J. Endocrinol. 1992. Vol. 134, № 1. P. 141-147.
Рецензия
Для цитирования:
, , , , , , , Ассоциация полиморфного варианта (CA)nгена кальцитонина (CALCA) с риском развитияпостменопаузального остеопороза и уровнемкальцитонина в сыворотке крови у русских женщинВолго-Уральского региона России. Остеопороз и остеопатии. 2009;12(1):2-6. https://doi.org/10.14341/osteo200912-6
For citation:
Selezneva L.I., Khusainova R.I., Nurlygayanov R.Z., Fazlyeva E.A., Ziganshin T.M., Kozhemyakina E.V., Lesnyak O.M., Khusnutdinova E.K. Assotsiatsiya polimorfnogo varianta (CA)ngena kal'tsitonina (CALCA) s riskom razvitiyapostmenopauzal'nogo osteoporoza i urovnemkal'tsitonina v syvorotke krovi u russkikh zhenshchinVolgo-Ural'skogo regiona Rossii. Osteoporosis and Bone Diseases. 2009;12(1):2-6. (In Russ.) https://doi.org/10.14341/osteo200912-6
Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).